review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Daniel H. Lowenstein | Q5217381 |
P2860 | cites work | Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit | Q27477887 |
Refractory status epilepticus | Q30436209 | ||
A comparison of rectal diazepam gel and placebo for acute repetitive seizures | Q30472245 | ||
Status epilepticus: new concepts | Q33607285 | ||
Propofol and midazolam in the treatment of refractory status epilepticus. | Q34301397 | ||
Propofol treatment of refractory status epilepticus: a study of 31 episodes | Q34330637 | ||
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review | Q34570571 | ||
A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group | Q34752382 | ||
The use of topiramate in refractory status epilepticus | Q35054480 | ||
Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures | Q35129615 | ||
Status epilepticus: a review of different syndromes, their current evaluation, and treatment | Q35155051 | ||
The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists | Q35475202 | ||
Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane | Q35864521 | ||
Efficacy of rapid IV administration of valproic acid for status epilepticus | Q36019170 | ||
Status epilepticus at an urban public hospital in the 1980s | Q39412907 | ||
Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus--experience in 102 adult patients | Q40434691 | ||
Refractory status epilepticus in adults | Q40826234 | ||
The epidemiology and management of status epilepticus | Q41743260 | ||
A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus | Q43731006 | ||
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus | Q43747004 | ||
Refractory status epilepticus: frequency, risk factors, and impact on outcome | Q43885520 | ||
A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia | Q44155514 | ||
Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity | Q44332082 | ||
Treatment of status epilepticus: a survey of neurologists | Q44454449 | ||
Propofol in status epilepticus: little evidence, many dangers? | Q44637466 | ||
Topiramate and status epilepticus: report of three cases | Q44708680 | ||
Determinants of mortality in status epilepticus | Q45088732 | ||
Treatment of epilepsy in adults: expert opinion, 2005. | Q46652012 | ||
Treatment with propofol: the new status quo for status epilepticus? | Q46664034 | ||
Propofol and thiopental for refractory status epilepticus in children | Q46664040 | ||
It's time to revise the definition of status epilepticus | Q46722956 | ||
Use of midazolam in the treatment of refractory status epilepticus. | Q51479446 | ||
Refractory status epilepticus: response to ketamine. | Q51485547 | ||
A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. | Q51521031 | ||
Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. | Q51523664 | ||
Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. | Q54048396 | ||
P921 | main subject | status epilepticus | Q980709 |
P304 | page(s) | 35-40 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Epilepsia | Q5382969 |
P1476 | title | The management of refractory status epilepticus: an update | |
P478 | volume | 47 Suppl 1 |
Q44542459 | A consensus-based approach to patient safety in epilepsy monitoring units: recommendations for preferred practices |
Q56776373 | A prehospital randomized trial in convulsive status epilepticus |
Q37976088 | A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus |
Q36828900 | Altered anxiety-related and abnormal social behaviors in rats exposed to early life seizures |
Q47731492 | An update on the recognition and treatment of non-convulsive status epilepticus in the intensive care unit |
Q40150721 | Association of seizure duration and outcome in refractory status epilepticus |
Q46227874 | Bowel ischemia: a rare complication of thiopental treatment for status epilepticus |
Q41407865 | Can status epilepticus sometimes just be a long seizure? |
Q40950416 | Clobazam: An effective add-on therapy in refractory status epilepticus |
Q64927994 | Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting. |
Q33414085 | Effectiveness of topiramate in medically complicated patients with status epilepticus or acute refractory seizures |
Q37078894 | How I treat status epilepticus in the Neuro-ICU. |
Q46818457 | Intravenous levetiracetam terminates refractory focal status epilepticus |
Q33892365 | Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. |
Q27028089 | Management of refractory status epilepticus in adults: still more questions than answers |
Q37781442 | Medical Management of Refractory Status Epilepticus |
Q33444384 | Predictors of refractoriness in a Turkish status epilepticus data bank |
Q38936491 | Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial |
Q34458158 | Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research |
Q48356194 | Propofol Infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation |
Q22001050 | Propofol infusion syndrome resuscitation with extracorporeal life support: a case report and review of the literature |
Q59051829 | Refractory Status Epilepticus: Experience in a Neurological Intensive Care Unit |
Q48089140 | Social play impairment following status epilepticus during early development. |
Q37781445 | Status Epilepticus Treatment and Outcome in Children: What Might the Future Hold? |
Q82865113 | Status epilepticus |
Q84691798 | Status epilepticus |
Q34565197 | Status epilepticus in the elderly: epidemiology, clinical aspects and treatment |
Q38107426 | Status epilepticus: an update |
Q46882959 | Suppressing cAMP response element-binding protein transcription shortens the duration of status epilepticus and decreases the number of spontaneous seizures in the pilocarpine model of epilepsy. |
Q37898797 | Update on pediatric epilepsy |
Q81086495 | [Status epilepticus] |
Search more.